According to CBDMT, the market and business intelligence company, the Alzheimer\'s disease (AD) market was valued at $5.5 billion in 2009. The AD market is led by North America with a market share of 52% accounting for sales of $2.8 billion. The Alzheimer disease market could account for more than $10.1 billion by 2020.